HER2-Positive Breast Cancer Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for HER2-Positive Breast Cancer medications. A condition association alone does not establish coverage.
What Is HER2-Positive Breast Cancer?
HER2-Positive Breast Cancer is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing HER2-Positive Breast Cancer with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Pharmacist insight
Medication adherence is particularly critical for oral chemotherapy agents. I work closely with patients to manage side effects that might cause them to skip doses. Many supportive care medications — anti-nausea drugs, growth factors — are available in generic form, helping reduce the overall cost burden of cancer treatment.
Angela C. Beverly, PharmD
About HER2-Positive Breast Cancer
HER2-positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2, leading to faster cell growth. While often aggressive, targeted therapies offer effective treatment options. TheDrugClub helps make these vital medications more affordable, easing the financial burden for patients and their families.
Understanding a diagnosis of HER2-positive breast cancer is a crucial first step in your treatment journey. This specific type of breast cancer is characterized by an overexpression of the HER2 protein on the surface of cancer cells. This protein acts like a growth signal, causing cancer cells to divide and spread more rapidly than other types of breast cancer.
Approximately one in five breast cancers are HER2-positive. While this diagnosis may sound daunting, significant advancements in medical science mean that HER2-positive breast cancer is now highly treatable, often with better outcomes than in the past, thanks to therapies specifically designed to target this protein.
Treatments for HER2-Positive Breast Cancer
The cornerstone of treatment for HER2-positive breast cancer is targeted therapy. These medications specifically block the HER2 protein, slowing or stopping cancer growth. Common targeted therapies include:
- Trastuzumab (Herceptin): Often given alongside chemotherapy, it binds to the HER2 protein on cancer cells.
- Pertuzumab (Perjeta): Used in combination with trastuzumab and chemotherapy, it targets a different part of the HER2 protein.
- Ado-trastuzumab emtansine (Kadcyla): An antibody-drug conjugate that delivers chemotherapy directly to HER2-positive cells.
- Fam-trastuzumab deruxtecan-nxki (Enhertu): Another antibody-drug conjugate used for advanced HER2-positive breast cancer.
In addition to targeted therapies, treatment plans often involve chemotherapy, radiation therapy, and surgery, tailored to your individual situation. These medications, especially the targeted therapies, can be very effective but also carry a significant cost.
How TheDrugClub Helps You Save on Prescriptions
Managing the cost of life-saving medications for HER2-positive breast cancer can be a major concern for many patients and their families. That's where TheDrugClub steps in. For a low monthly membership fee – just $19.95 for individuals or $3
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.